Search
for
Sort by
Research 361–390 of 777
- Biologics in the management of childhood atopic dermatitis
- Perspectives of Chinese Adult Patients with Alopecia Areata on Janus Kinase Inhibitors Therapy: A Qualitative Analysis Based on Social Media Platforms
- Cellular senescence and polycystic ovary syndrome: mechanisms and therapeutic strategies from a new perspective
- Towards cell-based therapy of alopecia areata: Autologous human Vδ2+ Foxp3+ γδTreg cells restore hair-follicle immune privilege and promote hair regrowth in human alopecia areata models ex vivo and in vivo
- Proceedings of the Ninth World Congress for Hair Research (2015)
- Dupilumab in Inflammatory Skin Diseases: A Systematic Review
- Resident Memory T Cells in Autoimmune Skin Diseases
- Recent Insights in Multi‐Target Drugs in Pharmacology and Medicinal Chemistry
- Ex Vivo Treatment with Allogenic Mesenchymal Stem Cells of a Healthy Donor on Peripheral Blood Mononuclear Cells of Patients with Severe Alopecia Areata: Targeting Dysregulated T Cells and the Acquisition of Immunotolerance
- Alopecia Areata: An Updated Review for 2023
- Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1
- Impact of Combined Baricitinib and FTI Treatment on Adipogenesis in Hutchinson–Gilford Progeria Syndrome and Other Lipodystrophic Laminopathies
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Single-cell analysis of temporal immune cell dynamics in alopecia areata reveals a causal role for clonally expanded CD8+ T cells in disease
- The Possible Role of Antibodies in Alopecia: A Narrative Review
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Alopecia Areata in Latin America: Where are We and Where are We Going?
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Treatment of Refractory Segmental Vitiligo and Alopecia Areata in a Child with Upadacitinib and NB-UVB: A Case Report
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- IL-15 Prolongs Anagen, Stimulates Proliferation, and Suppresses Apoptosis in the Hair Matrix of Human Scalp Hair Follicles
- Hair follicle immune privilege and its collapse in alopecia areata
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- Frontiers in alopecia areata pathobiology research
- Immunomodulatory Potential and Biocompatibility of Chitosan–Hydroxyapatite Biocomposites for Tissue Engineering
- Extracellular Vesicles in Skin: Biological Function and Therapeutic Potential
- Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention
- Seborrheic Dermatitis Revisited: Pathophysiology, Diagnosis, and Emerging Therapies—A Narrative Review
- Research Progress on Construction Technology of 3D Human Skin Models and Its Application Prospects in Dermatology
- Evaluation of Olive Oil-Based Formulations Loaded with Baricitinib for Topical Treatment of Alopecia Areata